Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1988 | 12-1987 | |
| Sales | 6,296,169 | 5,945,750 |
| Cost of Goods | 1,713,245 | 1,673,441 |
| Gross Profit | 4,201,462 | 4,272,309 |
| Operating Expenses | 4,065,226 | 3,637,859 |
| Operating Income | 517,943 | 634,891 |
| Interest Expense | 334,585 | 201,782 |
| Other Income | 769,637 | 362,350 |
| Pre-tax Income | 952,995 | 795,459 |
| Income Tax | 249,538 | 234,426 |
| Net Income Continuous | 703,457 | 561,033 |
| Net Income | $703,457 | $561,033 |
| EPS Basic Total Ops | 0.13 | 0.11 |
| EPS Basic Continuous Ops | 0.14 | 0.11 |
| EPS Diluted Total Ops | 0.14 | 0.11 |
| EPS Diluted Continuous Ops | 0.14 | 0.11 |
| EBITDA(a) | $840,685 | $966,220 |